Dihydropyridines

Sep 25, 2019

Katerzia(TM), the First and Only Amlodipine Oral Suspension, 1 mg/mL, is Now Commercially Available for Pediatric Patients 6 Years of Age and Older

Jul 10, 2019

FDA Approves Katerzia(TM), the First and Only Amlodipine Oral Suspension, 1 mg/mL, for Pediatric Patients 6 Years of Age and Older

May 30, 2019

Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress

Mar 06, 2019

World Nitrendipine (CAS 39562-70-4) Market Research Report 2019

Dec 20, 2018

The 2018 Amlodipine Market in China: Analysis & Outlook Through 2013-2022

Mar 06, 2018

Nimodipine Industry 2018-2025 Global Market Research Report

Oct 26, 2017

Kitov Pharmaceuticals Announces Phase III/IV Clinical Trial for KIT-302 Successfully Meets Primary Endpoint, and also Demonstrates Drug Candidate Improves Renal Function

Sep 20, 2017

Arbor Pharmaceuticals, LLC Launches New Nymalize® (nimodipine) Oral Solution 10 mL (30 mg) Unit Dose for the Treatment of Subarachnoid Hemorrhage